Our valuation analysis is based on a DCF reflecting a series of potential outcomes related to market penetration and consequent volume benefits. This yields a range of fair values between £35m and £107m (excluding the impact of any FY16 funding). Receipt of further volume orders should act as a catalyst towards our midcase fair value of £57m, which is based on the roll-out modelled in our estimates.
